Corporate Actions Earnings Reports Mergers and Acquisitions Acquisitions Executive Changes Corporate Earnings SharpLink Gaming Leadership Changes Stock Performance Management Changes Pharmaceuticals Retail Stocks Profit Reports Hims & Hers Robinhood Close Brothers H&T Group Retail Sector Apple Earnings Report Developer Disruptive Games NIKE, Inc. PwC Nvidia Bajaj Finance Corporate Performance Luxxfolio Holdings Inc. IPO Offerings Gemini Cybersecurity Teck Resources Mergers & Acquisitions Retail Ualá IPO Sector Performance Partnerships Earnings Surprises Galaxy Digital Updates BHP Jiuzi Holdings Strategic Partnerships Strategic Investments Kindly MD, Inc. Infosys Stock Price Movements Corporate Financing Radian Group Fair Issac Corporation Corporate Strategy TON Strategy Financial Results Corporate Governance Robinhood Markets Nike Exchange Filings Financial Performance Clarifications Executive Departures Bitmine Updates Executive Appointments Corporate Appointments Executive Retirement Airlines Boeing Individual Stocks Electric Vehicles De La Rue Bellway Palantir Technologies Technology Companies Technology Stocks
The deal targets Penumbra’s thrombectomy-focused neurovascular devices to deepen Boston Scientific’s cardiovascular reach.
